Clinical trial
PNU 166148 in Treating Patients With Metastatic Solid Tumors
NCT00004076 · University of Glasgow, Other · Unknown status
Key facts
| NCT number | NCT00004076 |
|---|---|
| Title | PNU 166148 in Treating Patients With Metastatic Solid Tumors |
| Official title | A Phase I Study to Evaluate MAG-CPT (PNU 166148) Given as One Single Intravenous Administration Every 4 Weeks in Patients With Advanced Solid Tumors |
| Lead sponsor | University of Glasgow, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | mureletecan |
| Enrollment | 30 |
| Start date | Jun 1, 1999 |
| First posted | Jun 17, 2004 |
| Last update posted | Dec 19, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: